Pharmaceuticals occupiers in Oslo typically cluster in Fornebu, plan ~220 sqft per seat at high-end fit-out ($185–270/sqft), and pay around 540 NOK/sqft ($50 USD) on Class A.
Pharmaceuticals occupiers in Oslo typically cluster in Fornebu, plan ~220 sqft per seat at high-end fit-out">fit-out ($185–270/sqft), and pay around 540 NOK/sqft ($50 USD) on Class A.
Pharmaceuticals occupiers in Oslo typically anchor in Fornebu. Energy (Equinor), telecom (Telenor), tech, professional services.
Class A rent in Oslo runs 540 NOK/sqft ($50 USD) on a 7-year lease with 8 months free. Prime submarkets sit at or modestly above the city index.
Typical pharmaceuticals fit-out targets high-end specification at $185–270/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 220 sqft per seat blended (workstation + circulation + amenity). A 100-headcount pharma office in Oslo typically targets 22,000 sqft of leasable area.
Commercial and medical-affairs teams cluster near academic-medical anchors; large floor plates support cross-functional brand teams. Strong energy, sovereign-wealth, shipping, and tech talent. Universitetet i Oslo, BI Norwegian Business School, and NTNU (Trondheim) anchor the pipeline. Multilingual (Norwegian, English) talent supports international tenancy.
Headline corporate tax: 22%. Norwegian double-net structure: tenant pays felleskostnader (operating costs) and indexed annual reviews (KPI / CPI). 5-10 year terms standard. Rent-free of 6-12 months on 10-year terms plus NOK 4000-7000/sqm TI typical.
| city | Oslo |
|---|---|
| industry | Pharmaceuticals |
| naics | 3254, 5417 |
| preferredSubmarket | Fornebu |
| preferredFitoutSpec | High-end |
| fitoutBand | $185–270/sqft |
| sqftPerSeat | 220 |
| classARentLocal | 540 NOK/sqft/yr |
| classARentUsd | $50/sqft/yr |
| vacancyPct | 6.4% |
| typicalLeaseYears | 7 |
| typicalRentFreeMonths | 8 |
| talentIndex | 84 |
| corporateTaxPct | 22% |
Reviewed by Class A Atlas Editorial Desk — House byline · global editorial team. Last updated 2026-04-15. See our methodology and editorial standards.